Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Comera Life Sciences Holdings, Inc. | 600,000 | reported | 27 Sept 2023 | tx 4+1,047,600 |
| FENNEC PHARMACEUTICALS INC. | 62,825 | reported | 31 May 2026 | tx 9+679,869 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 May 2026 | GRANT_AWARD | FENNEC PHARMACEUTICALS INC. | 1,159 | 0.00 USD | |
| 18 Feb 2026 | EXERCISE | FENNEC PHARMACEUTICALS INC. | 13,710 | 0.00 USD | |
| 16 May 2025 | PURCHASE | FENNEC PHARMACEUTICALS INC. | 1,035 | 6.75 USD | first after silence |
| 19 May 2025 | PURCHASE | FENNEC PHARMACEUTICALS INC. | 13,965 | 6.99 USD | |
| 28 Mar 2025 | GRANT_AWARD | FENNEC PHARMACEUTICALS INC. | 50,000 | 0.00 USD | deriv |
| 28 Mar 2025 | GRANT_AWARD | FENNEC PHARMACEUTICALS INC. | 75,000 | 0.00 USD | deriv |
| 15 Aug 2024 | GRANT_AWARD | FENNEC PHARMACEUTICALS INC. | 400,000 | 5.58 USD | deriv |
| 27 Sept 2023 | GRANT_AWARD | Comera Life Sciences Holdings, Inc. | 600,000 | 0.00 USD | deriv |
| 14 Feb 2023 | GRANT_AWARD | Comera Life Sciences Holdings, Inc. | 100,000 | 0.00 USD | deriv |
| 09 Sept 2022 | PURCHASE | Comera Life Sciences Holdings, Inc. | 47,600 | 2.06 USD | |
| 09 Aug 2022 | GRANT_AWARD | Comera Life Sciences Holdings, Inc. | 300,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 16 May 2025.